FDA approves Zolinza to treat cancer (AP via Yahoo! News)
A Merck & Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells.

FDA Approves Zolinza to Treat Cancer (San Francisco Chronicle)
A Merck & Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells. The Food and Drug Administration approved the drug, Zolinza, to treat advanced cases of cutaneous T-cell...

FDA approves Merck cancer drug Zolinza (Boston Globe)
A Merck & Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells. The Food and Drug Administration approved the drug, Zolinza, to treat advanced cases of cutaneous T-cell lymphoma, a rare cancer that's a form of non-Hodgkin's lymphoma. Roughly 20,000 Americans have the cancer, Merck said.